{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:13:03Z","timestamp":1790374383317,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T00:00:00Z","timestamp":1449705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T00:00:00Z","timestamp":1449705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/leu.2015.328","type":"journal-article","created":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T07:41:01Z","timestamp":1449733261000},"page":"844-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma"],"prefix":"10.1038","volume":"30","author":[{"given":"S","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Schuhmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Weniger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lollies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Thurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Rengstl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Brunnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Vornanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pfreundschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Benes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"K\u00fcppers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Newrzela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-L","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,10]]},"reference":[{"key":"BFleu2015328_CR1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1200\/JCO.2012.43.5958","volume":"31","author":"S Saarinen","year":"2013","unstructured":"Saarinen S, Pukkala E, Vahteristo P, Makinen MJ, Franssila K, Aaltonen LA . High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol 2013; 31: 938\u2013943.","journal-title":"J Clin Oncol"},{"key":"BFleu2015328_CR2","first-page":"1889","volume":"96","author":"I Anagnostopoulos","year":"2000","unstructured":"Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, Jaffe ES et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 2000; 96: 1889\u20131899.","journal-title":"Blood"},{"key":"BFleu2015328_CR3","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1084\/jem.20080809","volume":"205","author":"V Brune","year":"2008","unstructured":"Brune V, Tiacci E, Pfeil I, D\u00f6ring C, Eckerle S, van Noesel CJ et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 2008; 205: 2251\u20132268.","journal-title":"J Exp Med"},{"key":"BFleu2015328_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","volume":"17","author":"V Diehl","year":"1999","unstructured":"Diehl V, Sextro M, Franklin J, Hansmann ML, Harris N, Jaffe E et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol 1999; 17: 776\u2013783.","journal-title":"J Clin Oncol"},{"key":"BFleu2015328_CR5","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0046-8177(89)80007-3","volume":"20","author":"ML Hansmann","year":"1989","unstructured":"Hansmann ML, Stein H, Fellbaum C, Hui PK, Parwaresch MR, Lennert K . Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol 1989; 20: 1169\u20131175.","journal-title":"Hum Pathol"},{"key":"BFleu2015328_CR6","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1172\/JCI61245","volume":"122","author":"R K\u00fcppers","year":"2012","unstructured":"K\u00fcppers R, Engert A, Hansmann ML . Hodgkin lymphoma. J Clin Invest 2012; 122: 3439\u20133447.","journal-title":"J Clin Invest"},{"key":"BFleu2015328_CR7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","volume":"27","author":"Z Fan","year":"2003","unstructured":"Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA . Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 2003; 27: 1346\u20131356.","journal-title":"Am J Surg Pathol"},{"key":"BFleu2015328_CR8","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","volume":"122","author":"S Hartmann","year":"2013","unstructured":"Hartmann S, Eichenauer DA, Plutschow A, Mottok A, Bob R, Koch K et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 2013; 122: 4246\u20134252.","journal-title":"Blood"},{"key":"BFleu2015328_CR9","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1182\/blood-2003-02-0626","volume":"102","author":"L Boudova","year":"2003","unstructured":"Boudova L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell\/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell\/histiocyte-rich B-cell lymphoma. Blood 2003; 102: 3753\u20133758.","journal-title":"Blood"},{"key":"BFleu2015328_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ejh.12347","volume":"93","author":"DA Eichenauer","year":"2014","unstructured":"Eichenauer DA, Engert A . Antibodies and antibody-drug conjugates in the treatment of Hodgkin lymphoma. Eur J Haematol 2014; 93: 1\u20138.","journal-title":"Eur J Haematol"},{"key":"BFleu2015328_CR11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3324\/haematol.12875","volume":"93","author":"S Hartmann","year":"2008","unstructured":"Hartmann S, Martin-Subero JI, Gesk S, H\u00fcsken J, Giefing M, Nagel I et al. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization. Haematologica 2008; 93: 1318\u20131326.","journal-title":"Haematologica"},{"key":"BFleu2015328_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.20090528","volume":"206","author":"R Schmitz","year":"2009","unstructured":"Schmitz R, Hansmann ML, Bohle V, Martin-Subero JI, Hartmann S, Mechtersheimer G et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 2009; 206: 981\u2013989.","journal-title":"J Exp Med"},{"key":"BFleu2015328_CR13","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","volume":"110","author":"A Mottok","year":"2007","unstructured":"Mottok A, Renne C, Willenbrock K, Hansmann ML, Brauninger A . Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. Blood 2007; 110: 3387\u20133390.","journal-title":"Blood"},{"key":"BFleu2015328_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood-2002-05-1592","volume":"101","author":"I Wlodarska","year":"2003","unstructured":"Wlodarska I, Nooyen P, Maes B, Martin-Subero JI, Siebert R, Pauwels P et al. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood 2003; 101: 706\u2013710.","journal-title":"Blood"},{"key":"BFleu2015328_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/cncr.24819","volume":"116","author":"I Biasoli","year":"2010","unstructured":"Biasoli I, Stamatoullas A, Meignin V, Delmer A, Reman O, Morschhauser F et al. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group. Cancer 2010; 116: 631\u2013639.","journal-title":"Cancer"},{"key":"BFleu2015328_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","volume":"28","author":"M Al-Mansour","year":"2010","unstructured":"Al-Mansour M, Connors JM, Gascoyne RD, Skinnider B, Savage KJ . Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma. J Clin Oncol 2010; 28: 793\u2013799.","journal-title":"J Clin Oncol"},{"key":"BFleu2015328_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/1471-2407-14-332","volume":"14","author":"S Hartmann","year":"2014","unstructured":"Hartmann S, Eray M, Doring C, Lehtinen T, Brunnberg U, Kujala P et al. Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology. BMC Cancer 2014; 14: 332.","journal-title":"BMC Cancer"},{"key":"BFleu2015328_CR18","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","volume":"91","author":"R K\u00fcppers","year":"1994","unstructured":"K\u00fcppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994; 91: 10962\u201310966.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015328_CR19","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S1470-2045(14)70153-6","volume":"15","author":"R K\u00fcppers","year":"2014","unstructured":"K\u00fcppers R, D\u00fchrsen U, Hansmann ML . Pathogenesis, diagnosis, and treatment of composite lymphomas. Lancet Oncol 2014; 15: e435\u2013e446.","journal-title":"Lancet Oncol"},{"key":"BFleu2015328_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/bies.20085","volume":"26","author":"JC Ame","year":"2004","unstructured":"Ame JC, Spenlehauer C, de Murcia G . The PARP superfamily. Bioessays 2004; 26: 882\u2013893.","journal-title":"Bioessays"},{"key":"BFleu2015328_CR21","doi-asserted-by":"publisher","first-page":"7497","DOI":"10.4049\/jimmunol.177.11.7497","volume":"177","author":"R Lang","year":"2006","unstructured":"Lang R, Hammer M, Mages J . DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 2006; 177: 7497\u20137504.","journal-title":"J Immunol"},{"key":"BFleu2015328_CR22","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1159\/000362647","volume":"6","author":"R Ranjan","year":"2014","unstructured":"Ranjan R, Deng J, Chung S, Lee YG, Park GY, Xiao L et al. The transcription factor nuclear factor of activated T cells c3 modulates the function of macrophages in sepsis. J Innate Immun 2014; 6: 754\u2013764.","journal-title":"J Innate Immun"},{"key":"BFleu2015328_CR23","doi-asserted-by":"publisher","first-page":"e23971","DOI":"10.1371\/journal.pone.0023971","volume":"6","author":"A Goncalves","year":"2011","unstructured":"Goncalves A, Burckstummer T, Dixit E, Scheicher R, G\u00f3rna MW, Karayel E et al. Functional dissection of the TBK1 molecular network. PLoS One 2011; 6: e23971.","journal-title":"PLoS One"},{"key":"BFleu2015328_CR24","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1038\/sj.onc.1206822","volume":"22","author":"A George","year":"2003","unstructured":"George A, Morse HC 3rd, Justice MJ . The homeobox gene Hex induces T-cell-derived lymphomas when overexpressed in hematopoietic precursor cells. Oncogene 2003; 22: 6764\u20136773.","journal-title":"Oncogene"},{"key":"BFleu2015328_CR25","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1038\/sj.onc.1210285","volume":"26","author":"RG Ott","year":"2007","unstructured":"Ott RG, Simma O, Kollmann K, Weisz E, Zebedin EM, Schorpp-Kistner M et al. JunB is a gatekeeper for B-lymphoid leukemia. Oncogene 2007; 26: 4863\u20134871.","journal-title":"Oncogene"},{"key":"BFleu2015328_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nature09754","volume":"471","author":"C Steidl","year":"2011","unstructured":"Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, Farinha P et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 2011; 471: 377\u2013381.","journal-title":"Nature"},{"key":"BFleu2015328_CR27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/gcc.22276","volume":"54","author":"M Schneider","year":"2015","unstructured":"Schneider M, Schneider S, Zuhlke-Jenisch R, Klapper W, Sundstr\u00f6m C, Hartmann S et al. Alterations of the CD58 gene in classical Hodgkin lymphoma. Genes Chromosomes Cancer 2015; 54: 638\u2013645.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2015328_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","volume":"125","author":"J Reichel","year":"2015","unstructured":"Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y et al. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood 2015; 125: 1061\u20131072.","journal-title":"Blood"},{"key":"BFleu2015328_CR29","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1182\/blood-2005-10-3949","volume":"108","author":"A Liso","year":"2006","unstructured":"Liso A, Capello D, Marafioti T, Tiacci E, Cerri M, Distler V et al. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood 2006; 108: 1013\u20131020.","journal-title":"Blood"},{"key":"BFleu2015328_CR30","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1093\/emboj\/cdf389","volume":"21","author":"S Mathas","year":"2002","unstructured":"Mathas S, Hinz M, Anagnostopoulos I, Krappmann D, Lietz A, Jundt F et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J 2002; 21: 4104\u20134113.","journal-title":"EMBO J"},{"key":"BFleu2015328_CR31","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1152\/physrev.00050.2005","volume":"86","author":"F Lang","year":"2006","unstructured":"Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V . (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 2006; 86: 1151\u20131178.","journal-title":"Physiol Rev"},{"key":"BFleu2015328_CR32","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1073\/pnas.1205299110","volume":"110","author":"J Zhang","year":"2013","unstructured":"Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 2013; 110: 1398\u20131403.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015328_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","volume":"6","author":"L Pasqualucci","year":"2014","unstructured":"Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB et al. Genetics of follicular lymphoma transformation. Cell Rep 2014; 6: 130\u2013140.","journal-title":"Cell Rep"},{"key":"BFleu2015328_CR34","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1084\/jem.20131448","volume":"210","author":"G Fabbri","year":"2013","unstructured":"Fabbri G, Khiabanian H, Holmes AB, Wang J, Messina M, Mullighan CG et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J Exp Med 2013; 210: 2273\u20132288.","journal-title":"J Exp Med"},{"key":"BFleu2015328_CR35","doi-asserted-by":"publisher","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","volume":"94","author":"A Braeuninger","year":"1997","unstructured":"Braeuninger A, K\u00fcppers R, Strickler JG, Wacker HH, Rajewsky K, Hansmann ML . Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci USA 1997; 94: 9337\u20139342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015328_CR36","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1182\/blood.V99.6.2192","volume":"99","author":"S Oeschger","year":"2002","unstructured":"Oeschger S, Br\u00e4uninger A, K\u00fcppers R, Hansmann ML . Tumor cell dissemination in follicular lymphoma. Blood 2002; 99: 2192\u20132198.","journal-title":"Blood"},{"key":"BFleu2015328_CR37","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1073\/pnas.1121343109","volume":"109","author":"JG Lohr","year":"2012","unstructured":"Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA 2012; 109: 3879\u20133884.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015328_CR38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476: 298\u2013303.","journal-title":"Nature"},{"key":"BFleu2015328_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 2011; 471: 189\u2013195.","journal-title":"Nature"},{"key":"BFleu2015328_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2011.12.013","volume":"148","author":"T Rausch","year":"2012","unstructured":"Rausch T, Jones DT, Zapatka M, St\u00fctz AM, Zichner T, Weischenfeldt J et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 2012; 148: 59\u201371.","journal-title":"Cell"},{"key":"BFleu2015328_CR41","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.cell.2014.11.013","volume":"159","author":"J Qian","year":"2014","unstructured":"Qian J, Wang Q, Dose M, St\u00fctz AM, Zichner T, Weischenfeldt J et al. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell 2014; 159: 1524\u20131537.","journal-title":"Cell"},{"key":"BFleu2015328_CR42","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet 2013; 45: 970\u2013976.","journal-title":"Nat Genet"},{"key":"BFleu2015328_CR43","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1182\/blood-2003-03-0915","volume":"102","author":"AP Szremska","year":"2003","unstructured":"Szremska AP, Kenner L, Weisz E, Ott RG, Passegu\u00e9 E, Artwohl M et al. JunB inhibits proliferation and transformation in B-lymphoid cells. Blood 2003; 102: 4159\u20134165.","journal-title":"Blood"},{"key":"BFleu2015328_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.18632\/oncotarget.774","volume":"4","author":"B Schif","year":"2013","unstructured":"Schif B, Lennerz JK, Kohler CW, Bentink S, Kreuz M, Melzner I et al. SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients. Oncotarget 2013; 4: 35\u201347.","journal-title":"Oncotarget"},{"key":"BFleu2015328_CR45","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1074\/jbc.271.11.6497","volume":"271","author":"Y Chu","year":"1996","unstructured":"Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K . The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem 1996; 271: 6497\u20136501.","journal-title":"J Biol Chem"},{"key":"BFleu2015328_CR46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.humpath.2013.10.024","volume":"45","author":"V Leventaki","year":"2014","unstructured":"Leventaki V, Drakos E, Karanikou M, Psatha K, Lin P, Schlette E et al. c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma. Hum Pathol 2014; 45: 565\u2013572.","journal-title":"Hum Pathol"},{"key":"BFleu2015328_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10549-012-2161-y","volume":"135","author":"BA Hall","year":"2012","unstructured":"Hall BA, Kim TY, Skor MN, Conzen SD . Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression. Breast Cancer Res Treat 2012; 135: 469\u2013479.","journal-title":"Breast Cancer Res Treat"},{"key":"BFleu2015328_CR48","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1159\/000354486","volume":"32","author":"ST Towhid","year":"2013","unstructured":"Towhid ST, Liu GL, Ackermann TF, Beier N, Scholz W, Fuch\u00df T et al. Inhibition of colonic tumor growth by the selective SGK inhibitor EMD638683. Cell Physiol Biochem 2013; 32: 838\u2013848.","journal-title":"Cell Physiol Biochem"},{"key":"BFleu2015328_CR49","doi-asserted-by":"crossref","first-page":"26029","DOI":"10.18632\/oncotarget.4347","volume":"6","author":"D O'Neill","year":"2015","unstructured":"O'Neill D, Jones D, Wade M, Grey J, Nakjang S, Guo W et al. Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy. Oncotarget 2015; 6: 26029\u201326040.","journal-title":"Oncotarget"},{"key":"BFleu2015328_CR50","doi-asserted-by":"publisher","first-page":"32708","DOI":"10.1074\/jbc.M113.507210","volume":"288","author":"DR Brickley","year":"2013","unstructured":"Brickley DR, Agyeman AS, Kopp RF, Hall BA, Harbeck MC, Belova L et al. Serum- and glucocorticoid-induced protein kinase 1 (SGK1) is regulated by store-operated Ca2+ entry and mediates cytoprotection against necrotic cell death. J Biol Chem 2013; 288: 32708\u201332719.","journal-title":"J Biol Chem"},{"key":"BFleu2015328_CR51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1158\/0008-5472.457.65.2","volume":"65","author":"L Zhang","year":"2005","unstructured":"Zhang L, Cui R, Cheng X, Du J . Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase. Cancer Res 2005; 65: 457\u2013464.","journal-title":"Cancer Res"},{"key":"BFleu2015328_CR52","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00109-009-0525-5","volume":"87","author":"R Amato","year":"2009","unstructured":"Amato R, D'Antona L, Porciatti G, Agosti V, Menniti M, Rinaldo C et al. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation. J Mol Med (Berl) 2009; 87: 1221\u20131239.","journal-title":"J Mol Med (Berl)"},{"key":"BFleu2015328_CR53","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1038\/onc.2011.79","volume":"30","author":"UM Fagerli","year":"2011","unstructured":"Fagerli UM, Ullrich K, Stuhmer T, Holien T, K\u00f6chert K, Holt RU et al. Serum\/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells. Oncogene 2011; 30: 3198\u20133206.","journal-title":"Oncogene"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2015328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015328","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T03:28:42Z","timestamp":1692156522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2015328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,10]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFleu2015328"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.328","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,10]]},"assertion":[{"value":"15 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}